#CoronaVirus #COVID19 #biotechnology #CoronaOutbreak #biospace #CoronaPandemic #pharmaceuticals #lifesciences #Biopharma #entrepreneurs

Career And Jobs

On May 24, 2020

@IAmBiotech shared

#Biopharma Update on the Novel #Coronavirus https://t.co/QrH0i7a2qi https://t.co/YCd8PiY6zY

Open

Biopharma Update on the Novel Coronavirus: May 22

www.biospace.com

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 22, 2020.

On May 25, 2020

@Labiotech_eu shared

With the #coronavirus pandemic thrusting global industry sectors into chaos, #biotech investors and #entrepreneurs need to understand the financial big picture now more than ever. Download our latest ebook 'Biotech Money Insider 2020' to gain insights! 👇🏻 https://t.co/aghXmrBbMd

Open

What 2019 Can Teach About European Biotech Investments Going Forward

www.labiotech.eu

Following 2018’s bumper harvest for equity funding in European biotech, 2019 proved even more lucrative, particularly for private biotech companies. What are the biggest investment lessons ...

On May 20, 2020

@CellPressNews shared

RT @CellMentor: Small biotechs and startups are pivoting to address the COVID-19 pandemic. In our latest blog post, @labcentral co-founder @JFruehauf interviews execs from @AldatuBio, @Vaxess, @SentienBiotech, and @Affinivax about the changes they're facing. https://t.co/szZ9EG9gqQ https://t.co/8CIcGdf1UZ

Open

Meet the COVID busters: Biotech startups pivoting to address the pandemic

crosstalk.cell.com

Johannes Fruehauf, co-founder of LabCentral, interviews four biotech startup executives about their coronavirus response.

On May 21, 2020

@biospace shared

Biopharma Update on the Novel Coronavirus: May 21 #biospace #lifesciences #biotechnology #pharmaceuticals #CoronaVirus #COVID19 #CoronaOutbreak #CoronaPandemic https://t.co/dT51PWJl6N

Open

Biopharma Update on the Novel Coronavirus: May 21

www.biospace.com

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 21, 2020.

On May 22, 2020

@biospace shared

Sorrento Responds to Criticism of COVID-19 Neutralizing Antibodies #biospace #lifesciences #biotechnology #pharmaceuticals #CoronaVirus #COVID19 #CoronaOutbreak #CoronaPandemic https://t.co/DCmf40JQ6V

Open

Sorrento Responds to Criticism of COVID-19 Neutralizing Antibodies

www.biospace.com

Henry Li, Sorrento's co-founder, director, president and chief executive officer, did a follow-up interview with BioSpace to discuss the news and speculation surrounding it.

On May 21, 2020

@biospace shared

U.S. Government Provides AstraZeneca More Than $1 Billion for COVID-19 Vaccine #biospace #lifesciences #biotechnology #pharmaceuticals #CoronaVirus #COVID19 #CoronaOutbreak #CoronaPandemic https://t.co/jR8XjNsatA

Open

U.S. Government Provides AstraZeneca More Than $1 Billion for COVID-19 Vaccine

www.biospace.com

The U.S. Biomedical Advanced Research and Development Authority (BARDA) paid more than $1 billion to support the development, production and delivery of the vaccine beginning this fall.

On May 21, 2020

@SynBioBeta shared

.@Sherlock_Bio Launches Innovation Lab to Develop #COVID19 Diagnostics with $7.5 Million Grant from @open_phil Funding to Accelerate Development of INSPECTR™ Rapid Diagnostic Platform to Improve Testing in At-home and Low-resource Settings https://t.co/D6ST6DYINS

Open

Sherlock Biosciences Launches Innovation Lab to Develop COVID-19 Diagnostics with $7.5 Million Grant from Open Philanthropy

synbiobeta.com

Funding to Accelerate Development of INSPECTR™ Rapid Diagnostic Platform to Improve Testing in At-home and Low-resource Settings

On May 19, 2020

@BIOConvention shared

Thank you to @Genentech for your support of #BIODigital! See how they are participating in BIO Digital Week, June 8-12. https://t.co/U1vyLCk0Cg https://t.co/44CXR9OGpk

Open